Wednesday, September 23, 2026

Darling Ingredients Inc. And 7 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Darling Ingredients Inc. And 7 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

2. Preferred Bank

10.9% sales growth and 13.99% return on equity

Preferred Bank provides various commercial banking products and services to small and mid-sized businesses and their owners, entrepreneurs, real estate developers and investors, professionals, and high net worth individuals in the United States.

Preferred Bank's sales growth this year is anticipated to be 8.7% and 7.5% for next year.

Year-on-year quarterly revenue growth grew by 19.6%, now sitting on 154.22M for the twelve trailing months.

Preferred Bank's sales growth for the next quarter is 10.9%. The company's growth estimates for the current quarter and the next is 26.9% and 34%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.99%.

Volatility

Preferred Bank's last day, last week, and last month's current volatility was 3.81%, 1.48%, and 1.34%, respectively.

Preferred Bank's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.27% (day), 2.35% (last week), and 3.19% (last month), respectively.

Preferred Bank's Stock Yearly Top and Bottom Value

Preferred Bank's stock is valued at $67.49 at 20:22 EST, below its 52-week high of $67.73 and way above its 52-week low of $28.92.

Preferred Bank's Moving Average

Preferred Bank's value is above its 50-day moving average of $63.81 and way above its 200-day moving average of $48.31.

3. Darling Ingredients Inc.

18.6% sales growth and 10.73% return on equity

Darling Ingredients Inc. develops, produces, and sells natural ingredients from edible and inedible bio-nutrients.

Darling Ingredients Inc.'s sales growth this year is expected to be 11.9% and 0.2% for next year.

Year-on-year quarterly revenue growth grew by 18.7%, now sitting on 3.57B for the twelve trailing months.

Darling Ingredients Inc.'s sales growth for the next quarter is 18.6%. The company's growth estimates for the ongoing quarter and the next is 11.8% and 56.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.73%.

Volatility

Darling Ingredients Inc.'s last day, last week, and last month's current volatility was 2.53%, 1.67%, and 2.15%, respectively.

Darling Ingredients Inc.'s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.64% (day), 3.03% (last week), and 3.75% (last month), respectively.

Darling Ingredients Inc.'s Stock Yearly Top and Bottom Value

Darling Ingredients Inc.'s stock is valued at $71.44 at 20:22 EST, way under its 52-week high of $79.65 and way higher than its 52-week low of $18.36.

Darling Ingredients Inc.'s Moving Average

Darling Ingredients Inc.'s worth is below its 50-day moving average of $71.55 and way above its 200-day moving average of $57.78.

4. The Bank of Princeton

24.2% sales growth and 6.82% return on equity

The Bank of Princeton provides various banking products and services.

The Bank of Princeton's sales growth this year is expected to be 14% and a negative 0.8% for next year.

Year-on-year quarterly revenue growth grew by 18%, now sitting on 48.43M for the twelve trailing months.

The Bank of Princeton's sales growth for the next quarter is 24.2%. The company's growth estimates for the present quarter and the next is 54.5% and 28.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.82%.

Volatility

The Bank of Princeton's last day, last week, and last month's current volatility was 2.14%, 1.08%, and 1.51%, respectively.

The Bank of Princeton's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.40% (day), 1.77% (last week), and 2.88% (last month), respectively.

The Bank of Princeton's Stock Yearly Top and Bottom Value

The Bank of Princeton's stock is valued at $27.12 at 20:22 EST, under its 52-week high of $30.00 and way above its 52-week low of $17.40.

The Bank of Princeton's Moving Average

The Bank of Princeton's value is below its 50-day moving average of $27.95 and way higher than its 200-day moving average of $23.94.

5. Xylem Inc.

15.7% sales growth and 8.55% return on equity

Xylem Inc. engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications in the United States, Europe, the Asia Pacific, and internationally.

Xylem Inc.'s sales growth this year is expected to be 6.5% and 5.5% for next year.

Year-on-year quarterly revenue growth grew by 0.1%, now sitting on 4.88B for the twelve trailing months.

Xylem Inc.'s sales growth for the next quarter is 15.7%. The company's growth estimates for the current quarter and the next is 60.9% and 45%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.55%.

Volatility

Xylem Inc.'s last day, last week, and last month's current volatility was 1.21%, 0.90%, and 1.03%, respectively.

Xylem Inc.'s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.58% (day), 1.33% (last week), and 2.01% (last month), respectively.

Xylem Inc.'s Stock Yearly Top and Bottom Value

Xylem Inc.'s stock is valued at $107.11 at 20:22 EST, below its 52-week high of $108.84 and way above its 52-week low of $56.63.

Xylem Inc.'s Moving Average

Xylem Inc.'s worth is above its 50-day moving average of $102.79 and above its 200-day moving average of $97.65.

6. Installed Building Products, Inc.

18.1% sales growth and 34.17% return on equity

Installed Building Products, Inc., together with its subsidiaries, engages in the installation of insulation, waterproofing, fire-stopping, fireproofing, garage doors, rain gutters, window blinds, shower doors, closet shelving and mirrors, and other products in the continental United States.

Installed Building Products, Inc.'s sales growth this year is expected to be 15.8% and 9.3% for next year.

Year-on-year quarterly revenue growth grew by 10%, now sitting on 1.65B for the twelve trailing months.

Installed Building Products, Inc.'s sales growth for the next quarter is 18.1%. The company's growth estimates for the present quarter and the next is 33.3% and 33%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 34.17%.

Volatility

Installed Building Products, Inc.'s last day, last week, and last month's current volatility was 1.23%, 1.81%, and 2.58%, respectively.

Installed Building Products, Inc.'s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.45% (day), 3.46% (last week), and 4.48% (last month), respectively.

Installed Building Products, Inc.'s Stock Yearly Top and Bottom Value

Installed Building Products, Inc.'s stock is valued at $122.77 at 20:22 EST, under its 52-week high of $130.11 and way above its 52-week low of $35.56.

Installed Building Products, Inc.'s Moving Average

Installed Building Products, Inc.'s worth is higher than its 50-day moving average of $113.00 and way higher than its 200-day moving average of $107.89.

7. Inari Medical, Inc.

124.3% sales growth and 12.74% return on equity

Inari Medical, Inc., a commercial-stage medical device company, focuses on developing products to treat and transform the lives of patients suffering from venous diseases in the United States.

Inari Medical, Inc.'s sales growth this year is anticipated to be 67.6% and 26.5% for next year.

Year-on-year quarterly revenue growth grew by 144.4%, now sitting on 139.67M for the twelve trailing months.

Inari Medical, Inc.'s sales growth is a negative 0% for the ongoing quarter and 124.3% for the next. The company's growth estimates for the current quarter and the next is a negative 0% and 131.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.74%.

Volatility

Inari Medical, Inc.'s last day, last week, and last month's current volatility was 0.17%, 1.96%, and 2.74%, respectively.

Inari Medical, Inc.'s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.79% (day), 5.00% (last week), and 6.31% (last month), respectively.

Inari Medical, Inc.'s Stock Yearly Top and Bottom Value

Inari Medical, Inc.'s stock is valued at $113.64 at 20:22 EST, way under its 52-week high of $127.42 and way higher than its 52-week low of $39.55.

Inari Medical, Inc.'s Moving Average

Inari Medical, Inc.'s worth is above its 50-day moving average of $107.50 and way above its 200-day moving average of $86.95.

8. Baozun Inc.

37.2% sales growth and 9.76% return on equity

Baozun Inc. provides e-commerce solutions to brand partners in the People's Republic of China.

Baozun Inc.'s sales growth this year is anticipated to be 36.9% and 27.7% for next year.

Year-on-year quarterly revenue growth grew by 20.2%, now sitting on 8.85B for the twelve trailing months.

Baozun Inc.'s sales growth for the next quarter is 37.2%. The company's growth estimates for the current quarter and the next is 66.7% and negative -27.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.76%.

Volatility

Baozun Inc.'s last day, last week, and last month's current volatility was 3.93%, 2.80%, and 3.02%, respectively.

Baozun Inc.'s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 4.21% (day), 5.09% (last week), and 5.77% (last month), respectively.

Baozun Inc.'s Stock Yearly Top and Bottom Value

Baozun Inc.'s stock is valued at $35.15 at 20:22 EST, way under its 52-week high of $57.00 and way above its 52-week low of $25.69.

Baozun Inc.'s Moving Average

Baozun Inc.'s worth is way below its 50-day moving average of $44.11 and way under its 200-day moving average of $39.17.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Frontier AI Slowdown Call Splits Industry, Rattles Capex-Sensitive Markets
Anthropic's Dario Amodei publicly called for a coordinated global slowdown in frontier AI development, a stance Microsoft echoed with a 'humanist' AI code of conduct, but Nvidia and Meta's CEOs rejected any coordinated pause days later, exposing a widening rift between safety-focused and growth-focused AI leaders. The dispute landed amid growing financial scrutiny of AI infrastructure spending — a hyperscaler capex analysis, FTC warnings against antitrust waivers for AI firms, and an 8.6% single-day stock drop in GE Vernova tied directly to the slowdown remarks — signaling investors are newly nervous about whether the AI capex boom (including Alphabet's projected $701B revenue narrative) can be justified if the pace of development itself becomes contested.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,983
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,983 facts checked against source5,304 source documents archived
Query this data → isubstrate.com